Revance Therapeutics Stock (NASDAQ: RVNC) stock price, news, charts, stock research, profile.
Open | $6.59 |
Close | $6.60 |
Volume / Avg. | 2.67M / 3.67M |
Day Range | $6.58 - $6.60 |
52 Wk Range | 2.30 - 19.01 |
Market Cap | $687.59M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 77 |
Short Interest | 17.25% |
Days to Cover | 8.06 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Revance Therapeutics (NASDAQ:RVNC) through any online brokerage.
Other companies in Revance Therapeutics’s space includes: Theravance Biopharma (NASDAQ:TBPH), Zevra Therapeutics (NASDAQ:ZVRA), Third Harmonic Bio (NASDAQ:THRD), GH Research (NASDAQ:GHRS) and SNDL (NASDAQ:SNDL).
Revance Therapeutics has a consensus price target of $13.50.
The stock price for Revance Therapeutics (NASDAQ: RVNC) is $6.6 last updated August 23, 2024 at 7:51 PM EDT.
There are no upcoming dividends for Revance Therapeutics.
Revance Therapeutics’s Q3 earnings are confirmed for Wednesday, November 6, 2024.
There is no upcoming split for Revance Therapeutics.
Revance Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.